Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.30 |
| ▸ | F2 | P00734 | 1/20 | 0.30 |
| ▸ | PLAU | P00749 | 1/20 | 0.30 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.30 |
| ▸ | ELANE | P08246 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | AHR | P35869 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | CASP6 | P55212 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | GRK6 | P43250 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27683380 | 0.85 | DYRK1A (0.34) | — | |
| SCHEMBL6167693 | 0.82 | DYRK1A (0.35) | MEN1POLBKMT2AL3MBTL1 | |
| SCHEMBL28802178 | 0.77 | MAPT (0.36) | SMN1; SMN2LMNATDP1MEN1RAB9A | |
| SCHEMBL160276 | 0.73 | SMN1; SMN2 (0.51) | SMN1; SMN2 | |
| SCHEMBL377046 | 0.72 | HCAR2 (0.32) | — | |
| SCHEMBL16524045 | 0.71 | SMN1; SMN2 (0.37) | SMN1; SMN2LMNAMEN1POLBKMT2A | |
| SCHEMBL6169307 | 0.71 | DYRK1A (0.33) | SMN1; SMN2MEN1KMT2A | |
| SCHEMBL3931686 | 0.71 | HCAR2 (0.38) | — | |
| Water SCHEMBL7303697 | 0.71 | HCAR2 (0.32) | — | |
| SCHEMBL10399828 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3747454-B9 | AMYLOID-BETA BINDING PEPTIDES AND THESE PEPTIDES FOR USE IN THE THERAPY AND DIAGNOSIS OF ALZHEIMER'S DEMENTIA | PRIAVOID GMBH (DE) | 2023-10-04 | — | — | EP | disclosed |
| EP-3747454-B1 | AMYLOID-BETA BINDING PEPTIDES AND THESE PEPTIDES FOR USE IN THE THERAPY AND DIAGNOSIS OF ALZHEIMER'S DEMENTIA | PRIAVOID GMBH (DE) | 2023-06-07 | — | — | EP | disclosed |
| EP-3346273-B1 | NOVEL D-ENANTIOMERIC PEPTIDES DERIVED FROM D3 AND THEIR USE | PRIAVOID GMBH (DE) | 2023-01-04 | — | — | EP | disclosed |
| EP-3747454-A1 | AMYLOID-BETA BINDING PEPTIDES AND THEIR USE IN THE THERAPY AND DIAGNOSIS OF ALZHEIMER'S DEMENTIA | Forschungszentrum Jülich GmbH (DE) | 2020-12-09 | — | — | EP | disclosed |
| EP-3049099-B1 | AMYLOID-BETA-BINDING PEPTIDES AND THE USE THEREOF FOR THE THERAPY AND DIAGNOSIS OF ALZHEIMER'S DEMENTIA | FORSCHUNGSZENTRUM JUELICH GMBH (DE) | 2020-06-17 | — | — | EP | disclosed |
| EP-3271374-B1 | PEPTIDES WHICH BIND TO A SPECIFIC A-BETA-SPECIES FOR THE THERAPY AND/OR DIAGNOSIS OF ALZHEIMER'S DISEASE | FORSCHUNGSZENTRUM JUELICH GMBH (DE) | 2020-06-03 | — | — | EP | disclosed |
| EP-3558336-A1 | D-ENANTIOMERIC PEPTIDES FOR THE THERAPY OF CHRONIC AND NEUROPATHIC PAIN | Forschungszentrum Jülich GmbH (DE) | 2019-10-30 | — | — | EP | disclosed |
| EP-2895867-B1 | NOVEL D-ENANTIOMERIC PEPTIDES DERIVED FROM D3 AND USE THEREOF | FORSCHUNGSZENTRUM JUELICH GMBH (DE) | 2019-10-23 | — | — | EP | disclosed |
| EP-3296316-B1 | PEPTIDES FOR THE TREATMENT AND EARLY DIAGNOSIS OF ALZHEIMER'S DISEASE AND OTHER TAUOPATHIES | FORSCHUNGSZENTRUM JUELICH GMBH (DE) | 2019-05-22 | — | — | EP | disclosed |
| EP-3296315-B1 | PEPTIDES FOR THE TREATMENT AND EARLY DIAGNOSIS OF ALZHEIMER'S DISEASE AND OTHER TAUOPATHIES | FORSCHUNGSZENTRUM JUELICH GMBH (DE) | 2019-05-08 | — | — | EP | disclosed |
| EP-3271374-A1 | PEPTIDES WHICH BIND TO A SPECIFIC A-BETA-SPECIES FOR THE THERAPY AND/OR DIAGNOSIS OF ALZHEIMER'S DISEASE | Forschungszentrum Jülich GmbH (DE) | 2018-01-24 | — | — | EP | disclosed |
| WO-2016150415-A1 | PEPTIDES WHICH BIND TO A SPECIFIC A-BETA-SPECIES FOR THE THERAPY AND/OR DIAGNOSIS OF ALZHEIMER'S DISEASE | Forschungszentrum Jülich GmbH (DE) | 2016-09-29 | — | — | WO | disclosed |
| WO-2016150416-A1 | SPECIFIC AMYLOID BETA BINDING PEPTIDES AND THE USE OF SAME FOR TREATING AND DIAGNOSING ALZHEIMER'S DEMENTIA | Forschungszentrum Jülich GmbH (DE) | 2016-09-29 | — | — | WO | disclosed |
| EP-3049099-A1 | AMYLOID-BETA-BINDING PEPTIDES AND THE USE THEREOF FOR THE THERAPY AND DIAGNOSIS OF ALZHEIMER'S DEMENTIA | Forschungszentrum Jülich GmbH (DE) | 2016-08-03 | — | — | EP | disclosed |
| EP-2903999-A2 | PEPTIDES FOR THE TREATMENT AND EARLY DIAGNOSIS OF ALZHEIMER'S DISEASE AND OTHER TAUOPATHIES | Forschungszentrum Jülich Gmbh (DE) | 2015-08-12 | — | — | EP | disclosed |
| EP-2895867-A2 | NOVEL D-ENANTIOMERIC PEPTIDES DERIVED FROM D3 AND USE THEREOF | Forschungszentrum Jülich Gmbh (DE) | 2015-07-22 | — | — | EP | disclosed |
| WO-2015043567-A1 | AMYLOID-BETA-BINDING PEPTIDES AND THE USE THEREOF FOR THE THERAPY AND DIAGNOSIS OF ALZHEIMER'S DEMENTIA | Forschungszentrum Jülich GmbH (DE) | 2015-04-02 | — | — | WO | disclosed |
| WO-2014053110-A2 | PEPTIDES FOR THE TREATMENT AND EARLY DIAGNOSIS OF ALZHEIMER'S DISEASE AND OTHER TAUOPATHIES | Forschungszentrum Jülich GmbH (DE) | 2014-04-10 | — | — | WO | disclosed |
| WO-2014041115-A2 | NOVEL D-ENANTIOMERIC PEPTIDES DERIVED FROM D3 AND USE THEREOF | Forschungszentrum Jülich GmbH (DE) | 2014-03-20 | — | — | WO | disclosed |
| WO-2011147797-A2 | HYBRID COMPOUND, THE USE THEREOF, AND METHOD FOR THE PRODUCTION THEREOF | Forschungszentrum Jülich GmbH (DE) | 2011-12-01 | — | — | WO | disclosed |